Look out for the keynote by Richard Francis, CEO of Teva Pharmaceuticals, where he’ll discuss how Teva’s focus on innovation, sustaining its generics powerhouse, and its focus on growth engines is fuelling the company’s Pivot to Growth Strategy to build a rich portfolio of innovative medicines.

On the back of their 40th Anniversary event in Gamsen, Germany, Valsynthese posted their genuinely informative and entertaining short video that tells the company’s story from the perspective of its people.